Andrew Davis Speaks at the American Bar Association’s 2025 Midyear Tax Meeting
February 21, 2025
On February 20, 2025, Cravath partner Andrew T. Davis participated in the American Bar Association’s 2025 Midyear Tax Meeting, which was held from February 19-21 in Los Angeles. The event convened leading tax attorneys and government officials to discuss the latest federal, state and local tax policies and other topics. Andrew spoke on a panel entitled “CAMT Proposed Regulations,” which explored topics related to the recently released corporate alternative minimum tax (CAMT) proposed regulations, including CAMT’s application to multinational groups, CAMT considerations in M&A transactions and issues left unaddressed by the proposed regulations.
Related Practices & Industries
Speakers
- Photo
-
-
LL.M., 2020, New York University School of Law
-
J.D., 2014, Stanford Law School
-
A.B., 2010, Princeton University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
February 20, 2025
Cleveland-Cliffs Inc.’s High‑Yield Senior Guaranteed Notes Offering
Cravath represented the initial purchasers in connection with the $850 million 144A/Reg. S high‑yield senior guaranteed notes offering of Cleveland‑Cliffs Inc., a leading North America‑based steel producer. The transaction closed on February 6, 2025.
Deals & Cases
February 12, 2025
Smithfield Foods, Inc.’s IPO
Cravath represented the underwriters in connection with the $521.7 million initial public offering of common stock of Smithfield Foods, Inc., an American food company and an industry leader in value‑added packaged meats and fresh pork. The shares were listed on the Nasdaq Global Select Market. The transaction closed on January 29, 2025.
Deals & Cases
January 13, 2025
Johnson & Johnson’s $14.6 Billion Acquisition of Intra‑Cellular Therapies, Inc.
On January 13, 2025, Johnson & Johnson and Intra‑Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra‑Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, for $132 per share in cash for a total equity value of approximately $14.6 billion. Cravath is representing Johnson & Johnson in connection with the transaction.
Deals & Cases
January 06, 2025
Disney’s Combination of its Hulu + Live TV Business with Fubo
On January 6, 2025, The Walt Disney Company (“Disney”) and FuboTV Inc. (“Fubo) announced that they have entered into a definitive agreement for Disney to combine its Hulu + Live TV business with Fubo, forming a combined virtual MVPD company of which Disney will become the majority owner.
